Prostate Cancer, Genetic Susceptibility, and Risk of Chronic Non‐Urological Complications
Authors:
Open Access
- 29 April 2026
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 86 (9) , 1083-1090
Abstract
Background: Chronic nonurological complications are common among prostate cancer (PCa) survivors; however, their spectrum, magnitude, and genetic contribution remain poorly characterized. Methods: We evaluated 15 commonly reported nonurological complications and tested their associations with exposure to PCa and disease‐specific polygenic risk scores (PRS) in the UK Biobank (UKB; N = 219,133). Analyses were conducted using cause‐specific Cox proportional‐hazards models within a full‐cohort framework with time‐updated PCa status, delayed entry at study recruitment, and age as the underlying time scale. Results: After recruitment, incident PCa was diagnosed in 13,780 men, of which 1,656 (12.02%) had metastatic PCa (mPCa). Risks for seven complications were higher among men with PCa, adjusting for genetic background (all p < 0.05), including osteoporosis, venous thromboembolism, depression, and four primary cancers (bladder, kidney, colorectal, and pancreatic). Risks were consistently stronger among men exposed to mPCa than non‐mPCa; for example, the hazard ratio (HR) (95% confidence interval) for osteoporosis was 1.88 (1.63–2.18) for any PCa, 4.67 (3.11–7.01) for mPCa, and 1.75 (1.50–2.04) for non‐mPCa. Elevated risks for three additional complications (coronary artery disease, type 2 diabetes and chronic obstructive pulmonary disease) were observed only among men with mPCa. The risks for these ten complications were further increased among men with higher disease‐specific PRS; for example, the HR for osteoperosis in mPCa patients in the top PRS quartile was 13.57 (8.24–22.34) compared with men without PCa ( p < 0.001). Conclusion: PCa diagnosis and inherited genetic susceptibility jointly contribute to increased risks of multiple chronic non‐urological complications among survivors.Keywords
This publication has 46 references indexed in Scilit:
- Long-Term Adverse Effects and Complications After Prostate Cancer TreatmentJAMA Oncology, 2024
- Heritability of Alzheimer's disease plasma biomarkers: A nuclear twin family designAlzheimer's & Dementia, 2024
- A practical guide for assessing and managing cardiovascular risk during androgen‐deprivation therapy in patients with prostate cancerCancer, 2024
- Systematic comparison of family history and polygenic risk across 24 common diseasesThe American Journal of Human Genetics, 2022
- Association between medical androgen deprivation therapy and long‐term cardiovascular disease and all‐cause mortality in nonmetastatic prostate cancerInternational Journal of Cancer, 2022
- Causes of Death Among Patients With Metastatic Prostate Cancer in the US From 2000 to 2016JAMA Network Open, 2021
- Cause of death during prostate cancer survivorship: A contemporary, US population–based analysisCancer, 2021
- Familial Risk and Heritability of Cancer Among Twins in Nordic CountriesJAMA, 2016
- Genetics of Male OsteoporosisCalcified Tissue International, 2001
- Modeling Survival Data: Extending the Cox Model2000